NIH-funded research R01 grant

Understanding how cerebrospinal fluid flow affects Alzheimer's disease and mild cognitive impairment

Official title: Intrinsic CSF outflow metrics for mild cognitive impairment and Alzheimer's disease

Funded at University of California, San Diego · NIH-11086176 · Data updated 2026-11-12

This study is looking at how the flow of fluid in the brain might affect memory and thinking in older adults with Alzheimer's or mild cognitive issues, and it will use special imaging to see how things like sleep and exercise could play a role in keeping our brains healthy.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startMay 15, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$688,104
NIH project number5R01AG087407-02
Project IDNIH-11086176 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 65 and older who may be experiencing cognitive decline or are at risk for Alzheimer's disease.

Less likely to help

Patients under the age of 65 or those without cognitive impairment may not benefit from this research.

What this research studies

This research investigates the role of cerebrospinal fluid (CSF) flow in the development of Alzheimer's disease (AD) and mild cognitive impairment (MCI) in older adults. By examining how the glymphatic system, which helps clear waste from the brain, functions in humans, the study aims to identify potential contributors to cognitive decline. The research will utilize advanced imaging techniques to observe CSF dynamics and assess how factors like sleep and physical activity may influence this process. Participants may undergo non-invasive imaging to help understand the relationship between CSF flow and cognitive health.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or slowing the progression of Alzheimer's disease and mild cognitive impairment.

How similar studies have gone: Previous studies in animal models have shown promising results regarding glymphatic clearance and cognitive function, but this research aims to translate those findings to human subjects.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Miyazaki, Mitsue — University of California, San Diego
  • Study coordinator: Miyazaki, Mitsue

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.